Sequencing of cabazitaxel and abiraterone acetate following docetaxel in metastatic castration-resistant prostate cancer (mCRPC)

被引：2
|
作者：
Schnadig, Ian D.
Bhor, Menaka
Vogelzang, Nicholas J.
Hennessy, Daniel
Nicacio, Leonardo V.
Berry, William R.
Hutson, Thomas E.
Fleming, Mark T.
Cowey, C. Lance
Saravanan, Shanmugapriya
Dhanda, Rahul
Sonpavde, Guru
机构：
[1] McKessson Specialty Hlth, Compass Oncol, Tualatin, OR USA
[2] McKesson Special Hlth, The Woodlands, TX USA
[3] US Oncol Network, The Woodlands, TX USA
[4] Comprehens Canc Ctr Nevada, Las Vegas, NV USA
[5] Sanofi, Medfield, MA USA
[6] Sanofi, Bridgewater, NJ USA
[7] US Oncol, Canc Ctr North Carolina, Raleigh, NC USA
[8] Texas Oncol Baylor Charles A Sammons Canc Ctr, Dallas, TX USA
[9] Virginia Oncol Associates, Norfolk, VA USA
[10] Texas Oncol PA, Baylor Charles A Sammons Canc Ctr, Dallas, TX USA
[11] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.79
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
79
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer
    Auchus, Richard J.
    Yu, Margaret K.
    Nguyen, Suzanne
    Mundle, Suneel D.
    [J]. ONCOLOGIST, 2014, 19 (12): : 1231 - 1240
  • [32] Cabazitaxel after docetaxel: a new option in metastatic castration-resistant prostate cancer
    Lheureux, Stephanie
    Joly, Florence
    [J]. BULLETIN DU CANCER, 2012, 99 (09) : 875 - 880
  • [33] Efficacy of abiraterone acetate in post-docetaxel castration-resistant prostate cancer
    Vogiatzi, Paraskevi
    Claudio, Pier Paolo
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (07) : 1027 - 1030
  • [34] TOLERABILITY OF CABAZITAXEL IN SENIOR ADULTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) IN EUROPE
    Heidenreich, A.
    Bracarda, S.
    Mason, M.
    Ozen, H.
    Sengelov, L.
    Gerritsen, W.
    Papandreou, C.
    Fossa, S.
    Hitier, S.
    Climent, M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 307 - 307
  • [35] Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy
    Sternberg, C. N.
    Molina, A.
    North, S.
    Mainwaring, P.
    Fizazi, K.
    Hao, Y.
    Rothman, M.
    Gagnon, D. D.
    Kheoh, T.
    Haqq, C. M.
    Cleeland, C.
    de Bono, J. S.
    Scher, H. I.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (04) : 1017 - 1025
  • [36] Cabazitaxel for metastatic castration-resistant prostate cancer (mCRPC) real data in real life
    Manneh Kopp, R.
    Alonso Gordoa, T.
    Celiz, P.
    Sepulveda, J. M.
    Grande, E.
    CastellanoGauna, D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S499 - S500
  • [37] Effects of abiraterone acetate and enzalutamide on muscle and adipose mass in men with metastatic castration-resistant prostate cancer (mCRPC)
    Ileana, Ecaterina
    Antoun, Sami
    Albiges, Laurence
    Massard, Christophe
    Di Palma, Mario
    Escudier, Bernard J.
    Fizazi, Karim
    Loriot, Yohann
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] INTERMITTENT (RECHALLENGE) CHEMOTHERAPY WITH DOCETAXEL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)
    Bracarda, Sergio
    Rossi, Marta
    Hamzaj, Alketa
    De Angelis, Verena
    De Simone, Valeria
    Caserta, Claudia
    Crino, Lucio
    [J]. ANNALS OF ONCOLOGY, 2009, 20
  • [39] Assessment of prognostic factors in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with abiraterone acetate (AA) after docetaxel (DOC).
    Cavaliere, Carla
    Caffo, Orazio
    Ortega, Cinzia
    D'aniello, Carmine
    Di Napoli, Marilena
    Cecere, Sabrina Chiara
    Della Pepa, Chiara
    Crispo, Anna
    Maines, Francesca
    Ruatta, Fiorella
    Iovane, Gelsomina
    Montella, Maurizio
    Pignata, Sandro
    Facchini, Gaetano
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Comparison of abiraterone acetate (Abi) versus ketoconazole (Keto) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) refractory to docetaxel (D)
    Peer, Avivit
    Ish-Shalom, Maya
    Maimon, Natalie
    Gottfried, Maya
    Boursi, Ben
    Leibowitz-Amit, Raya
    Berger, Raanan
    Neumann, Avivit
    Kovel, Svetlana
    Sella, Avishay
    Pili, Roberto
    Hammers, Hans J.
    Sinibaldi, Victoria J.
    Carducci, Michael Anthony
    Eisenberger, Mario A.
    Keizman, Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
12345